Idiopathic Pulmonary Fibrosis Treatment Market size is expected to reach USD 2200 million by 2030 at 6.7% CAGR during the forecast period 2022-2030. Market Overview: Idiopathic Pulmonary Fibrosis (IPF) is a progressive and fatal lung disease characterized by the scarring of lung tissue, leading to impaired respiratory function and ultimately respiratory failure. Despite being considered a...